Optimi Health is trading 5.81% down at $4.70 after no clear company-specific announcement was identified for September 2, 2026.
- Its latest reported corporate catalyst was an August 14 discretionary equity facility allowing up to US$100 million in share sales.
- The facility may create dilution concerns but is not a same-day event.
- Broader equities and biotech are trading higher, so no reliable sector or market explanation is evident.